Later, Guo et al. confirmed that downregulating SETDB1 enhanced ICB response in ovarian cancer, showing that SETDB1 repression activated interferon signaling through both cGAS‐STING and RNA sensing pathways.41 The gene discussed is SETDB1; the disease is ovarian carcinoma.